BNP Paribas Asset Management
RYTM icon

BNP Paribas Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

BNP Paribas Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.82M Buy
43,872
+41,457
+1,717% +$4.03M ﹤0.01% 925
2025
Q4 		$259K Buy
2,415
+1,918
+386% +$203K ﹤0.01% 1308
2025
Q3 		$50K Buy
497
+76
+18% +$7.06K ﹤0.01% 1064
2025
Q2 		$27K Buy
+421
New +$25.8K ﹤0.01% 1389

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BNP Paribas Asset Management's RYTM Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Rhythm Pharmaceuticals (RYTM) stake by 1,717% in Q1 2026, buying an estimated $4.03M and bringing the position to 43,872 shares worth $3.82M. The position accounts for ﹤0.01% of the portfolio, ranked #925.

BNP Paribas Asset Management first reported a position in RYTM in Q2 2025 and has held it in 4 quarters since. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • BNP Paribas Asset Management held 43,872 shares of Rhythm Pharmaceuticals worth $3.82M as of Q1 2026.
  • BNP Paribas Asset Management bought 41,457 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $4.03M.
  • Rhythm Pharmaceuticals made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #925 holding.
  • BNP Paribas Asset Management first reported a position in Rhythm Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.